Skip to main content
SpringerLink
Log in

The adverse effects of muromonab CD3 may be reduced

  • Incidence study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

The adverse effects of muromonab CD3 may be reduced. React. Wkly. 462, 2 (1993). https://doi.org/10.2165/00128415-199304620-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-199304620-00003

Keywords

Search

Navigation